ArticleCell communication and signaling : CCS2015

Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis.

Stephan Philipp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.